Crinetics Pharmaceuticals (CRNX) Cash from Operations (2017 - 2026)

Crinetics Pharmaceuticals' quarterly Cash from Operations came in at 124703000.0 in Q1 2026, down 40.98% year-on-year from 211303035.5 in Q1 2025, and down 34.23% quarter-over-quarter from 92901000.0 in Q4 2025.

Crinetics Pharmaceuticals has reported Cash from Operations for 10 years, with the latest figure at 124703000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Operations fell 40.98% year-over-year to 124703000.0; the trailing twelve-month figure through Mar 2026 stood at 414173000.0 (down 55.83% YoY), and the FY2025 full-year result was 377922000.0, down 64.18% from the prior year.
  • Cash from Operations for Q1 2026 stood at 124703000.0, down from 92901000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 13543000.0 in Q1 2022, with the low at 124703000.0 in Q1 2026.
  • Average Cash from Operations over 5 years is 59801294.12, with a median of 47644000.0 recorded in 2024.
  • Year-over-year, Cash from Operations jumped 32.51% in 2022 and sank 200.66% in 2023.
  • Tracing CRNX's Cash from Operations over 5 years: stood at 35207000.0 in 2022, then retreated by 15.9% to 40806000.0 in 2023, then sank by 63.88% to 66871000.0 in 2024, then plunged by 38.93% to 92901000.0 in 2025, then plunged by 34.23% to 124703000.0 in 2026.
  • The last three Cash from Operations figures came in at 124703000.0 (Q1 2026), 92901000.0 (Q4 2025), and 110718000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -1.67 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -12.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -2.49 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.43 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 1.08 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 70.50 Mn
10 Crinetics Pharmaceuticals 3.59 Bn 3.59 Bn 10.53 Mn -124.70 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -124.70 Mn
Mar 31, 2026 -124.70 Mn
Dec 31, 2025 -92.90 Mn
Dec 31, 2025 -92.90 Mn
Sep 30, 2025 -110.72 Mn
Sep 30, 2025 -110.72 Mn
Jun 30, 2025 -85.85 Mn
Jun 30, 2025 -85.85 Mn
Mar 31, 2025 -88.45 Mn
Mar 31, 2025 -88.45 Mn
Dec 31, 2024 -66.87 Mn
Dec 31, 2024 -66.87 Mn
Sep 30, 2024 -62.82 Mn
Sep 30, 2024 -62.82 Mn
Jun 30, 2024 -47.64 Mn
Jun 30, 2024 -47.64 Mn
Mar 31, 2024 -52.86 Mn
Mar 31, 2024 -52.86 Mn
Dec 31, 2023 -40.81 Mn
Dec 31, 2023 -40.81 Mn
Sep 30, 2023 -41.34 Mn
Sep 30, 2023 -41.34 Mn
Jun 30, 2023 -45.74 Mn
Jun 30, 2023 -45.74 Mn
Mar 31, 2023 -40.72 Mn
Mar 31, 2023 -40.72 Mn
Dec 31, 2022 -35.21 Mn
Dec 31, 2022 -35.21 Mn
Sep 30, 2022 -38.48 Mn
Sep 30, 2022 -38.48 Mn
Jun 30, 2022 -27.98 Mn
Jun 30, 2022 -27.98 Mn
Mar 31, 2022 -13.54 Mn
Mar 31, 2022 -13.54 Mn
Dec 31, 2021 -22.90 Mn
Dec 31, 2021 -22.90 Mn
Sep 30, 2021 -25.67 Mn
Sep 30, 2021 -25.67 Mn
Jun 30, 2021 -19.95 Mn
Jun 30, 2021 -19.95 Mn
Mar 31, 2021 -20.07 Mn
Mar 31, 2021 -20.07 Mn
Dec 31, 2020 -15.94 Mn
Dec 31, 2020 -15.94 Mn
Sep 30, 2020 -18.00 Mn
Sep 30, 2020 -18.00 Mn
Jun 30, 2020 -15.86 Mn
Jun 30, 2020 -15.86 Mn
Mar 31, 2020 -12.23 Mn
Mar 31, 2020 -12.23 Mn
Dec 31, 2019 -13.45 Mn
Dec 31, 2019 -13.45 Mn
Sep 30, 2019 -13.61 Mn
Sep 30, 2019 -13.61 Mn
Jun 30, 2019 -12.57 Mn
Jun 30, 2019 -12.57 Mn
Mar 31, 2019 -6.76 Mn
Mar 31, 2019 -6.76 Mn
Dec 31, 2018 -6.01 Mn
Dec 31, 2018 -6.01 Mn
Sep 30, 2018 -5.69 Mn
Sep 30, 2018 -5.69 Mn
Jun 30, 2018 -4.35 Mn
Jun 30, 2018 -4.35 Mn
Mar 31, 2018 -3.41 Mn
Mar 31, 2018 -3.41 Mn
Dec 31, 2017 -2.51 Mn
Dec 31, 2017 -2.51 Mn
Sep 30, 2017 -2.44 Mn
Sep 30, 2017 -2.44 Mn